NDC 70518-3772 – Clindamycin Hydrochloride

Clindamycin Hydrochloride 300 mg/1 · Capsule · Oral

Human Prescription Drug 2 recalls

Product NDC70518-3772

Product details

Brand name
Clindamycin Hydrochloride
Generic name
Clindamycin Hydrochloride
Labeler
REMEDYREPACK INC.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA216957
Marketed since
June 21, 2023
Listing expires
December 31, 2027
Pharmacologic class
Lincosamide Antibacterial

Active ingredients

Uses, dosage, side effects and warnings for Clindamycin Hydrochloride →

Package NDC codes (6)

Package NDCDescriptionSince
70518-3772-030 CAPSULE in 1 BLISTER PACK (70518-3772-0)Jun 21, 2023
70518-3772-128 CAPSULE in 1 BLISTER PACK (70518-3772-1)Aug 21, 2023
70518-3772-230 CAPSULE in 1 BOTTLE, PLASTIC (70518-3772-2)Sep 5, 2023
70518-3772-321 CAPSULE in 1 BLISTER PACK (70518-3772-3)Dec 4, 2023
70518-3772-421 CAPSULE in 1 BOTTLE, PLASTIC (70518-3772-4)Jan 10, 2024
70518-3772-514 CAPSULE in 1 BOTTLE, PLASTIC (70518-3772-5)Sep 24, 2025

Recalls mentioning this NDC

Other Clindamycin Hydrochloride products